Health
12 stories in this blend
There's An AI For That·5d agoHow to check if your cat is experiencing physical pain using facial expression scoring
Learn how to assess your cat for subtle signs of discomfort by applying the Feline Grimace Scale visual guidelines. This method allows pet owners to generate an objective rating to share with a veterinarian.
There's An AI For That·Sep 23Smartwatches Can Estimate Blood Vessel Age from Wrist Pulses
Researchers from Peking University and OPPO trained an AI system on pulse recordings from over half a million smartwatch users. The technology measures arterial stiffness to estimate biological vascular age, helping identify heightened risks for high blood pressure and cardiovascular events.
Superhuman·Sep 13Apple Watch Series 12
Apple's updated smartwatch features enhanced health sensors that monitor heart activity at regular intervals. The system processes cardiovascular metrics to give users personal insights regarding physical training and recovery needs.
Superhuman·Sep 6Synthetic biological implants stimulate continuous muscle contractions in animal studies
Scientists in China developed engineered muscle grafts that contract autonomously without requiring neural activity. In animal trials, the self-activating tissues helped maintain bone density, physical endurance, and muscle volume. The innovation is intended to help bedridden or elderly individuals who cannot perform physical exercise.
Superhuman·Aug 30Experimental gene therapy yields long term cholesterol reduction
In a human trial, the experimental gene therapy VERVE-102 lowered bad LDL cholesterol levels by up to 62 percent with a single dose. By disabling a targeted liver gene, the therapy maintained reduced cholesterol for a full year without requiring daily medication.
Superhuman·Aug 30FitBit Luffu Link family health monitor
A screenless wristband built for families seeking to monitor the health of relatives without standard fitness tracking menus or displays. It aims to quietly share health indicators with loved ones.
Superhuman·Aug 30FDA approves drug targeting mutated KRAS proteins for pancreatic cancer
The Food and Drug Administration granted regulatory approval for daraxonrasib, a oral medication targeting mutated KRAS proteins in pancreatic cancer. In clinical trials, the drug extended median survival times beyond 13 months, effectively doubling the life expectancy compared to conventional chemotherapy.
Superhuman·Aug 30Brain protein mapping reveals key targets for autism treatments
Researchers at the University of California, San Francisco mapped over 100 proteins associated with severe autism. The analysis showed how genetic mutations break molecular bonds, offering clear direction for developing targeted therapies.
Superhuman·Aug 30Single dose gene treatment produces lasting cholesterol reduction
University College London researchers tested a gene therapy named VERVE-102 that deactivates a liver gene responsible for regulating LDL levels. Trial results showed a 62 percent reduction in bad cholesterol that persisted for a year.
There's An AI For That·Aug 28Evaluate sleep routines to identify key recovery disruptions
This diagnostic prompt reviews a user's recent nightly sleep log to pinpoint the single primary habit causing poor rest. It replaces broad recommendations with a practical, one-week test and concrete tracking criteria.
There's An AI For That·Aug 25Machine learning accelerates genetic therapies for reversing cellular aging
Researchers utilized artificial intelligence to redesign key genetic sequences previously shown to reverse cellular damage in sight impaired mice. The computer generated gene variants achieved fifty times higher efficacy than the natural versions discovered over prior decades of manual biological research.
The Neuron·Aug 20Personalized mRNA skin cancer therapy achieves success in late-stage clinical trial
Pharmaceutical companies Merck and Moderna announced positive Phase 3 trial results for an individualized melanoma treatment designed with artificial intelligence. Algorithms examine each patient's blood and tumor mutations to target specific proteins, creating a tailored vaccine administered alongside standard immunotherapy.
